Cargando…
Targeting enzymes for cancer therapy: old enzymes in new roles.
Enzymes which traditionally have played no role in cell-directed cytotoxicity are finding their way into schemes for prodrug activation and immunotoxins owing to such useful enzymatic activity. Alkaline phosphatase, carboxypeptidases, beta-glucosidases and beta-lactamases among many others are being...
Autores principales: | Deonarain, M. P., Epenetos, A. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033521/ https://www.ncbi.nlm.nih.gov/pubmed/7947082 |
Ejemplares similares
-
Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.
por: Deonarain, M. P., et al.
Publicado: (1998) -
Generation of a selectively cytotoxic fusion protein against p53 mutated cancers
por: Kousparou, Christina A, et al.
Publicado: (2012) -
The moonlighting enzyme CD13: old and new functions to target
por: Mina-Osorio, Paola
Publicado: (2008) -
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1
por: Pericleous, L M, et al.
Publicado: (2005) -
Pancreatic Proteolytic Enzymes and Cancer: New Support for an Old Theory
por: Isaacs, Linda L.
Publicado: (2022)